stocksEMCURE
EMCURE

Emcure Pharmaceuticals Ltd.

1,783.20-19.5 (-1.08%)
17 Jul, 12:00 AM

Annual Reports and Financial Documents

Emcure Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
202420252026
Annual ReportsFY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Emcure Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Analyst / Investor Meet15 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation for Earnings Call - Q1 FY27
  • Board Meeting15 Jul 2026
    Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026
    Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Unaudited Financial ....
  • Press Release / Media Release13 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release titled - "Emcure Consolidates Gennova Ownership; Sharpens Focus on Biologics; Samit Mehta Leads the Next Phase of Growth"
  • Acquisition13 Jul 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition
  • Restructuring11 Jul 2026
    Announcement under Regulation 30 (LODR)-Restructuring
    Slump sale of a division of Gennova Biopharmaceuticals Limited, Subsidiary of the Company
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026.
  • Acquisition3 Jul 2026
    Announcement under Regulation 30 (LODR)-Acquisition
    Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015 - Acquisition / Investment in step-down subsidiary by subsidiary
  • Change in Management30 Jun 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Change in Senior Management Personnel of the Company
  • Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window
  • Allotment of ESOP / ESPS19 Jun 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Allotment of 20,600 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013
  • Reg.24(A)-Annual Secretarial Compliance27 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
  • Analyst / Investor Meet20 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule of Analyst/ Investor Meeting on June 09, 2026
  • Analyst / Investor Meet20 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule of Analyst/ Investor Meeting on June 01, 2026
  • Analyst / Investor Meet20 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule of Analyst/ Investor Meeting on May 27, 2026
  • Analyst / Investor Meet20 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule of Analyst/ Investor Meeting on May 26, 2026
  • General16 May 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - US FDA Inspection At Our Formulations Facility Located At Sanand, Ahmedabad, Gujarat, India.
    Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - US FDA inspection of our formulations facility located at Sanand, Ahmedabad, ....
  • Analyst / Investor Meet11 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Transcript of Earnings Call - Q4 FY26
  • General8 May 2026
    Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating
    Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - ESG Rating
  • Newspaper Publication6 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Audited Financial Results of the Company for the quarter and year ended March 31, 2026
  • Analyst / Investor Meet5 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio recording of Earnings Call - Q4 FY26

Frequently Asked Questions

Where can I download the annual report of Emcure Pharmaceuticals Ltd.?
Annual reports of Emcure Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Emcure Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Emcure Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Emcure Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Emcure Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Emcure Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Emcure Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Emcure Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Emcure Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Emcure Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Emcure Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Emcure Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Emcure Pharmaceuticals Ltd. is INE168P01015. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Emcure Pharmaceuticals Ltd. listed?
Emcure Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is EMCURE and the BSE code is -.
Where can I find the shareholding pattern of Emcure Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Emcure Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Emcure Pharmaceuticals Ltd. on Sharpely?
Share price data for Emcure Pharmaceuticals Ltd. is updated as of 17 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.